NCT04765839View on ClinicalTrials.gov

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 12, 2021

Primary Completion Date

April 3, 2021

Study Completion Date

April 3, 2021

Conditions
Vaccine Preventable Disease
Interventions
OTHER

Educational, culturally appropriate COVID-19 messages

Educational, culturally appropriate COVID-19 messages will be developed and shared by RHCP.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04765839 - Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations | Biotech Hunter | Biotech Hunter